Results 171 to 180 of about 1,751,474 (312)

Geospatial and phylogenetic clustering of acute and recent HIV infections in Lilongwe, Malawi. [PDF]

PLOS Glob Public Health
Bell GJ, Powers KA, Ratmann O, Dennis AM, Mmodzi P, Matoga M, Jere E, Chen JS, Maierhofer CN, Rutstein SE, Lancaster KE, Chagomerana MB, Bonongwe N, Mathiya E, Ndalama B, Bonsall D, Weir SS, Hosseinipour MC, Emch M, Cohen MS, Hoffman IF, Miller WC.   +21 more
europepmc   +1 more source

Vasculitis-Like Hemorrhagic Herpes Zoster and HIV Infections: An Intricate Association. [PDF]

Cureus, 2023
Cozma EC, Banciu LM, Soare C, Găman MA, Voiculescu VM.   +4 more
europepmc   +1 more source

Long‐acting cabotegravir and rilpivirine in people with HIV receiving chronic anticoagulation: A real‐world case series

British Journal of Clinical Pharmacology, EarlyView.
Background Long‐acting intramuscular cabotegravir plus rilpivirine (LA‐CAB + RPV) is an effective maintenance antiretroviral regimen for virologically suppressed people with HIV. However, its use in individuals receiving chronic anticoagulation is limited by concerns regarding intramuscular bleeding risk, and real‐world data are scarce.
Montserrat Laguno, Berta Torres, Maria Martínez‐Rebollar, Paula Arreba, Octavi Roman, Roger LLobet, Leire Berrocal, Alberto Foncillas, Júlia Calvo, Abiu Sempere, Ivan Chivite, Elisa de Lazzari, Josep Mallolas, Ana González‐Cordón   +13 more
wiley   +1 more source

Prevalence of HCV and HIV infections and evaluation of ALT Levels in Patients with transfusion-dependent thalassemia: a cross-sectional study from Nanning, China. [PDF]

Ann Hematol
Li B, Huang L, Yan X, Wang X, Li J, Lai R, Lai M, Xie H, Sun J, He B, Chen L, Li S.   +11 more
europepmc   +1 more source

Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti, Giada Wyttenbach, Mario G. Bianchetti, Camilla Lavagno, Pietro Camozzi, Gregorio P. Milani, Renato Gualtieri, Sebastiano A. G. Lava, Pietro B. Faré, Simone Janett   +9 more
wiley   +1 more source

HIV Infections and Prevention in Women. [PDF]

Clin Obstet Gynecol
Powell AM.
europepmc   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor, Stefano Comai, Gianfranco Pasut, Franco Folli, Marco Gentilucci, Negar Gharavi, Sofia Raitsin, Thuy Van Nguyen, Marco Pappagallo, Andrea Mattarei, Paolo L. Manfredi, Sara De Martin   +11 more
wiley   +1 more source

Seroprevalences and factors associated with HBV, HCV and HIV infections in haemodialysis patients in rural areas of Gabon. [PDF]

Ghana Med J
Ekomy MH, Ngoubadjambo AM, Ntsounga EM, Begouabe H, Ekouaghe LPA, Togola M, Moubeyi LOM, Obiang CS.   +7 more
europepmc   +1 more source

Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation

Biopharmaceutics &Drug Disposition, EarlyView.
Pharmacokinetic interactions between Echinacea and two antiviral drugs, favipiravir and atazanavir, were assessed in rats. The findings suggest that Echinacea does not significantly affect the pharmacokinetics of favipiravir and atazanavir. These results provide preliminary evidence that concurrent use of Echinacea with these antiviral drugs may be ...
Siva Nageswara Rao Gajula, Jeevan Sai Kallam, Aarika Kanukolanu, Ganesh Korada, Lakshmi Vineela Nalla   +4 more
wiley   +1 more source

Individual and population-level risk factors for new HIV infections among adults in Eastern and Southern Africa. [PDF]

Nat Commun
Slaymaker E, Calvert C, Marston M, Risher K, Imai-Eaton JW, Moorhouse L, Price A, Abdul R, Dube A, Nabukalu D, Obor D, McLean E, Tlhajoane M, Tomlin K, Urassa M, Baisley K, Crampin A, Geubbels E, Gregson S, Herbst K, Kwaro D, Lutalo T, Newton R, Todd J, ALPHA Network.   +24 more
europepmc   +1 more source